This is very good news - would anyone care to speculate on ...
1. how long would we expect to recruit 4o patients? and what
2. What is the likely timeline to hear about results? is this a few years or earlier based on typical progression.
It is another Keytruda play, so I am not sure if this helps create BP competition.
But I think this is a very good development.
Regards
Ann: Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $421.2M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 28.5¢ | $751.3K | 2.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 307462 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 118494 | 4 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |